Stability of target hemoglobin levels during the first year of epoetin treatment in patients with chronic kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 2, Issue 5, 2007, Pages 938-946

  De Nicola, Luca ^a   Conte, Giuseppe ^a   Chiodini, Paolo ^a   Cianciaruso, Bruno ^b   Pota, Andrea ^b   Bellizzi, Vincenzo ^c   Tirino, Giuseppina ^a   Avino, Deborah ^a   Catapano, Fausta ^a   Minutolo, Roberto ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c Clinical Laboratory Analysis   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; BLOOD; CHRONIC DISEASE; FEMALE; HUMAN; KIDNEY DISEASE; MALE; MIDDLE AGED; TIME;

ANEMIA; CHRONIC DISEASE; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMOGLOBINS; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; TIME FACTORS;

EID: 34548863931     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01690407     Document Type: Article

References (35)

1. Horl W, Macdougall IC, Rossert J, Rutkowski B, Wauters JP, Valderrabano F: Predialysis survey on anemia management: Patient referral. Am J Kidney Dis 41: 49-61, 2003
2. Levin A, Djurdjev O, Duncan J, Rosenbaum D, Werb R: Haemoglobin at time of referral prior to dialysis predicts survival: An association of haemoglobin with long-term outcomes. Nephrol Dial Transplant 21: 370-377, 2006
3. De Nicola L, Minutolo R, Chiodini P, Zamboli P, Zoccali C, Castellino P, Donadio C, Strippoli M, Casino F, Giannattasio M, Petrarulo F, Virgilio M, Laraia E, Di Iorio BR, Savica V, Conte G; TArget Blood Pressure LEvels in Chronic Kidney Disease (TABLE in CKD) Study Group: Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention. Kidney Int 69: 538-545, 2006
4. Minutolo R, Sasso FC, Chiodini P, Cianciaruso B, Carbonara O, Zamboli P, Tirino G, Pota A, Torella R, Conte G, De Nicola L: Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: A comparative analysis in nephrology, diabetology and primary care settings. J Hypertens 24: 1655-1661, 2006
5. Walker AM, Schneider G, Yeaw J, Nordstrom B, Robbins S, Pettitt D: Anemia as a predictor of cardiovascular events in patients with elevated serum creatinine. J Am Soc Nephrol 17: 2293-2298, 2006
6. Abramson JL, Jurkovitz CT, Vaccarino V, Weintraub WS, McClellan W: Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population. The ARIC Study. Kidney Int 64: 610-615, 2003
7. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ: Kidney function and anemia as risk factors for coronary heart disease and mortality. The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 151: 492-500, 2006
8. Kovesdy CP, Trivedi BK, Kalantar-Zadeh K, Anderson JE: Association of anemia with outcomes in men with moderate and severe chronic kidney disease. Kidney Int 69: 560-564, 2006
9. Iseki K, Ikemiya Y, Iseki C, Takishita S: Haematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 18: 899-905, 2003
10. Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD: Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int 66: 1131-1138, 2004
11. Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt K, Horl WH, Macdougall IC, Macleod A, Wiecek A, Cameron S: Revised European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 19[Suppl 2]: 1-47, 2004
12. National Kidney Foundation: K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47[Suppl 31: S1-S146, 2006
13. Drüeke TB, Locatelli F, Clyne N, Eckardt K, Macdougall IC, Tsakiris D, Burger H, Scherhag A; for the CREATE Investigators: Normalization of haemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006
14. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D; for the CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006
15. Ritz E, Laville M, Bilous RW, O'Donoghue D, Scherhag A, Burger U, de Alvaro F; on behalf of the ACORD Investigators: Target level for hemoglobin correction in patients with diabetes and CKD: Primary results of the Anemia Correction in Diabetes (ACORD) study. Am J Kidney Dis 49: 194-207, 2007
16. Phrommintikul A, Haas SJ, Elsik M, Klum H: Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: A meta-analysis. Lancet 369: 381-388, 2007
17. Hsu CY, McCulloch CE, Curhan GC: Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol 13: 2783-2786, 2002
18. Xue JL, St. Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40: 1153-1161, 2002
19. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Bommer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK: Anemia management and outcomes from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44: 94-111, 2004
20. Lacson E, Ofsthun N, Lazarus JM: Effect of variability in anemia management on haemoglobin outcomes in ESRD. Am J Kidney Dis 41: 111-124, 2003
21. Fishbane S, Berns JS: Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68: 1337-1343, 2005
22. Ebben JP, Gilbertson DT, Foley RN, Collins AJ: Hemoglobin level variability: Associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1: 1205-1210, 2006
23. Regidor DL, Kopple JD, Kovesdy CP, Kilpatrick RD, McAllister CJ, Aronovitz J, Greenland S, Kalantar-Zadeh K: Association between changes in haemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 17: 1181-1191, 2006
24. Matthews JNS, Altman DG, Campbell MJ, Royston P: Analysis of serial measurements in medical research. BMJ 300: 230-235, 1990
25. Bellizzi V, Minutolo R, Terracciano V, Iodice C, Giannattasio P, De Nicola L, Conte G, Di Iorio BR: Influence of the cyclic variation of hydration status on hemoglobin levels in hemodialysis patients. Am J Kidney Dis 40: 549-555, 2002
26. Di Iorio BR, Minutolo R, De Nicola L, Zamboli P, Trucillo P, Catapano F, Cristofano C, Scalfi L, Conte G; on behalf of the ERIKA Study Group: Supplemented very low protein diet ameliorates responsiveness to crythropoietin in chronic renal failure. Kidney Int 64: 1822-1828, 2003
27. Ifudu O: Patient characteristics determining rHuEPO dose requirement. Nephrol Dial Transplant 17[Suppl 5]: 38-41, 2002
28. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, Delosreyes G, Friedman E: Gender modulates responsiveness to recombinant erythropoietin. Am J Kidney Dis 38: 518-522, 2001
29. Besarab A, Levin A: Defining a renal anemia management period. Am J Kidney Dis 36[Suppl 3]: S13-S23, 2000
30. Rossert J, Fouqueray B, Boffa JJ: Anemia management and the delay of chronic renal failure progression. J Am Soc Nephrol 14[Suppl]: S173-S177, 2003
31. Bellizzi V, Sabbatini M, Fuiano G, Sansone G, Magri P, Uccello F, Andreucci M, De Nicola L, Cianciaruso B: The impact of early normalization of hematocrit by erythropoietin on renal damage in remnant rats. Nephrol Dial Transplant 13: 2210-2215, 1998
32. Gouva C, Nikolopoulos P, Ioarmidis JP, Siamopoulos KC: Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 66: 753-760, 2004
33. Rossert J, Levin A, Roger SD, Horl WH, Fouqueray B, Gassmann-Mayer C, Frei D, McClellan WM: Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 47: 738-750, 2006
34. Pocock SJ, Elbourne DR: Randomized trials or observational tribulations? N Engl J Med 342: 1907-1909, 2000
35. Locatelli F, Pisoni RL, Akizawa T, Cruz JM, DeOreo PB, Lameire NH, Held PJ: Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns Study (DOPPS) findings. Am J Kidney Dis 44[Suppl 2]: S27-S33, 2004